CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-06 | Ausiello Dennis A Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −9,000 | 0 | ||
| 2024-08-06 | Ausiello Dennis A Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −11,250 | 0 | ||
| 2024-08-01 | Greenstreet Yvonne Chief Executive Officer | Exercise or conversion 10b5-1 | +15,148 | $85.00 | $1.3M | 88,589 |
| 2024-08-01 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −15,148 | $270.00 | $4.1M | 73,441 |
| 2024-08-01 | Greenstreet Yvonne Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −15,148 | 17,352 | ||
| 2024-07-11 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −7,093 | $261.00 | $1.9M | 73,441 |
| 2024-06-25 | SCHULMAN AMY W Director | Exercise or conversion 10b5-1 | +8,500 | $131.21 | $1.1M | 16,936 |
| 2024-06-25 | SCHULMAN AMY W Director | Sale 10b5-1 | −8,500 | $240.00 | $2.0M | 8,436 |
| 2024-06-25 | SCHULMAN AMY W Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −8,500 | 2,750 | ||
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −78 | $221.71 | $17K | 17,634 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −17 | $224.17 | $4K | 17,617 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −24 | $225.55 | $5K | 17,593 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −45 | $226.82 | $10K | 17,548 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −169 | $228.30 | $39K | 17,379 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −348 | $229.06 | $80K | 17,031 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −398 | $229.93 | $92K | 16,633 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −129 | $231.59 | $30K | 16,504 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −283 | $232.54 | $66K | 16,221 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −151 | $233.53 | $35K | 16,070 |
| 2024-06-25 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −242 | $234.66 | $57K | 15,828 |
Page 43 of 80 · 1,590 trades